A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

Clinical trial NCT03523728 · TERMINATED

Trial details

NCT number: NCT03523728
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Polycystic Kidney, Autosomal Dominant

Start date: 2018-10-04
Primary completion: 2021-08-03
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.